Regorafenib Monohydrate
99%
- Product Code: 102271
CAS:
1019206-88-2
| Molecular Weight: | 500.83 g./mol | Molecular Formula: | C₂₁H₁₅ClF₄N₄O₃H₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD26142360 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Regorafenib monohydrate is primarily used in the treatment of certain types of cancer. It is effective in managing metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). The compound works by inhibiting multiple kinases involved in tumor growth, angiogenesis, and the tumor microenvironment. This targeted approach helps to slow down the progression of cancer and improve survival rates in patients who have not responded to other treatments. It is typically administered orally, allowing for convenient use in outpatient settings. Regular monitoring is essential to manage potential side effects and ensure optimal therapeutic outcomes.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 98.5-100 |
| Water | 2-5% |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿2,190.00 |
+
-
|
| 0.025 | 10-20 days | ฿3,990.00 |
+
-
|
| 0.100 | 10-20 days | ฿6,990.00 |
+
-
|
| 0.500 | 10-20 days | ฿11,250.00 |
+
-
|
Regorafenib Monohydrate
Regorafenib monohydrate is primarily used in the treatment of certain types of cancer. It is effective in managing metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). The compound works by inhibiting multiple kinases involved in tumor growth, angiogenesis, and the tumor microenvironment. This targeted approach helps to slow down the progression of cancer and improve survival rates in patients who have not responded to other treatments. It is typically administered orally, allowing for convenient use in outpatient settings. Regular monitoring is essential to manage potential side effects and ensure optimal therapeutic outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :